Bambusa Therapeutics, Inc. Common Stock

BBTX

Valor de mercado US$ 801 mi

15,73 USD

-0,12

0,76%

No fechamento Atualizado 6 de nov. 16:00 EST

1 dia

-0,76%

5 dias

4,94%

1 mês

4,94%

3 meses

4,94%

6 meses

4,94%

No acumulado do ano

4,94%

1 ano

4,94%

5 anos

4,94%

10 anos

4,94%

Sobre: Bambusa Therapeutics Inc is a clinical-stage biotechnology company developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases.

Saúde Biotecnologia

Notícias

Positivo

Neutro

Negativo

Sentimento 3 meses

Positivo 0%

Neutro 100%

Negativo 0%

Neutro

Seeking Alpha

há 8 dias

U.S. IPO Weekly Recap: Anthropic Files For Potentially Record-Breaking IPO

Three IPOs, one direct listing, and two SPACs priced during a challenging week for growth stocks. Just one SPAC is currently scheduled to list in the week ahead, although some smaller deals may also join the calendar throughout the week. Street research is expected for two companies in the week ahead, and six lock-up periods will be expiring.

Ver ranking de notícias

Gráficos de preços implementados com Lightweight Charts™

Bambusa Therapeutics, Inc. Common Stock BBTX Valor de mercado US$ 801 mi

Notícias

Bambusa Therapeutics, Inc. Common Stock

BBTX

Valor de mercado US$ 801 mi